Wednesday, 18 November 2026European Markets

SEQUANA MEDICAL Stock Bullish By 14% At Session Start Today

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(VIANEWS) - Shares of SEQUANA MEDICAL (BEL 20: SEQUA.BR) jumped by a staggering 14.81% to 6.20 € at 10:25 EST on Wednesday, following the last session's upward trend. BEL 20 is jumping 1.23% to 3,920.71 €, after three successive sessions in a row of losses. This seems, so far, an all-around up trend trading session today.

About SEQUANA MEDICAL

Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.

Earnings Per Share

As for profitability, SEQUANA MEDICAL has a trailing twelve months EPS of -1.25 €.

Volume

Today's last reported volume for SEQUANA MEDICAL is 46733 which is 1157.95% above its average volume of 3715.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

SEQUANA MEDICAL's stock is considered to be oversold (<=20).

More news about SEQUANA MEDICAL (SEQUA.BR).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

Spotted an error? Use “Correct this article” (bottom right), or select any sentence, to report it or respond to that point.

  1. Published before we listed source documents with each article.
  2. Published 8 Feb 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›